{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:28:28Z","timestamp":1784914108494,"version":"3.55.0"},"reference-count":203,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Clostridial neurotoxins, botulinum neurotoxins (BoNTs), and tetanus neurotoxin (TeNT) are potent toxins responsible for severe diseases, botulism and tetanus, respectively. BoNTs associate with non-toxic proteins (non-toxic non-hemagglutinin, hemagglutinins, and OrfXs), which protect BoNTs against acidic pH and protease degradation and facilitate BoNT passage through the intestinal barrier. TeNT enters motor neurons and undergoes a retrograde axonal transport until the target inhibitory interneurons in the central nervous system. BoNTs and TeNT recognize specific cell surface receptors which consist of complex sets of protein(s)-glycan-gangliosides and determine specific cell entry pathways. Recent data on structural and functional investigations of BoNT and TeNT receptors bring a better understanding of toxin trafficking in the host and entry into target neuronal cells, which is useful for the development of updated strategies of prevention and treatment of the corresponding diseases. Since clostridial neurotoxins, notably BoNTs, are important therapeutic tools, detailed knowledge of their activity opens the way of the development of engineered molecules for specific clinical applications.<\/jats:p>","DOI":"10.3390\/toxins18010035","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:20:37Z","timestamp":1768206037000},"page":"35","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in Clostridial Neurotoxins: Passage of the Intestinal Barrier and Targeting of Specific Neuronal Cells"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9305-8989","authenticated-orcid":false,"given":"Michel R.","family":"Popoff","sequence":"first","affiliation":[{"name":"Unit\u00e9 des Toxines Bact\u00e9riennes, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, CNRS UMR 2001 INSERM U1306, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1146\/annurev-biochem-013118-111654","article-title":"Botulinum and Tetanus Neurotoxins","volume":"88","author":"Dong","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Poulain, B., and Popoff, M.R. (2019). Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?. Toxins, 11.","DOI":"10.3390\/toxins11010034"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A Novel Strain of Clostridium Botulinum That Produces Type B and Type H Botulinum Toxins","volume":"209","author":"Barash","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jit450","article-title":"Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene","volume":"209","author":"Dover","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1021\/ac504716v","article-title":"Functional Characterization of Botulinum Neurotoxin Serotype H as a Hybrid of Known Serotypes F and A (BoNT F\/A)","volume":"87","author":"Kalb","year":"2015","journal-title":"Anal. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-33570-9_1","article-title":"Genetic Diversity within Clostridium Botulinum Serotypes, Botulinum Neurotoxin Gene Clusters and Toxin Subtypes","volume":"Volume 364","author":"Hill","year":"2012","journal-title":"Botulinum Neurotoxins"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Peck, M.W., Smith, T.J., Anniballi, F., Austin, J.W., Bano, L., Bradshaw, M., Cuervo, P., Cheng, L.W., Derman, Y., and Dorner, B.G. (2017). Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature. Toxins, 9.","DOI":"10.3390\/toxins9010038"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1038\/s41598-019-47551-4","article-title":"The Population Structure of Clostridium Tetani Deduced from Its Pan-Genome","volume":"9","author":"Plourde","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1038\/s41467-023-41174-0","article-title":"Ancient Clostridium DNA and Variants of Tetanus Neurotoxins Associated with Human Archaeological Remains","volume":"14","author":"Hodgins","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","article-title":"Domain Organization in Clostridium Botulinum Neurotoxin Type E Is Unique: Its Implication in Faster Translocation","volume":"386","author":"Kumaran","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1111\/j.1742-4658.2011.08183.x","article-title":"Molecular Structures and Functional Relationships in Clostridial Neurotoxins","volume":"278","author":"Swaminathan","year":"2011","journal-title":"FEBS J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/febs.17004","article-title":"NTNH Protein: More than a Bodyguard for Botulinum Neurotoxins","volume":"291","author":"Gao","year":"2024","journal-title":"FEBS J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.1214270","article-title":"Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex","volume":"335","author":"Gu","year":"2012","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/jb.172.5.2498-2503.1990","article-title":"Purification and Characterization of a Protease from Clostridium Botulinum Type A That Nicks Single-Chain Type A Botulinum Neurotoxin into the Di-Chain Form","volume":"172","author":"Dekleva","year":"1990","journal-title":"J. Bacteriol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37324","DOI":"10.1038\/s41598-025-21372-0","article-title":"Elucidating the Activation Mechanism of Botulinum Neurotoxin a: Role of \u03b1-Clostripain and NTNH","volume":"15","author":"Pitel","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Stringer, S.C., Carter, A.T., Webb, M.D., Wachnicka, E., Crossman, L.C., Sebaihia, M., and Peck, M.W. (2013). Genomic and Physiological Variability within Group II (Non-Proteolytic) Clostridium Botulinum. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-333"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00438-014-0887-4","article-title":"Complete Nucleotide Sequence of a Plasmid Containing the Botulinum Neurotoxin Gene in Clostridium Botulinum Type B Strain 111 Isolated from an Infant Patient in Japan","volume":"289","author":"Hosomi","year":"2014","journal-title":"Mol. Genet. Genom."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eadx5058","DOI":"10.1126\/sciadv.adx5058","article-title":"Structure of the Complete 14-Subunit Botulinum Neurotoxin B Complex Reveals a Unique Anchoring through the Narrow Central Pore of HA70","volume":"11","author":"Nowakowska","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eadx5831","DOI":"10.1126\/sciadv.adx5831","article-title":"A Nut-and-Bolt Assembly of the Bimodular Large Progenitor Botulinum Neurotoxin Complex","volume":"11","author":"Lam","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lee, K., Gu, S., Jin, L., Le, T.T.N., Cheng, L.W., Strotmeier, J., Kruel, A.M., Yao, G., Perry, K., and Rummel, A. (2013). Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003690"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"24777","DOI":"10.1074\/jbc.M703446200","article-title":"A Novel Subunit Structure of Clostridium Botulinum Serotype D Toxin Complex with Three Extended Arms","volume":"282","author":"Hasegawa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.1128\/AEM.70.12.7192-7199.2004","article-title":"Differentiation of the Gene Clusters Encoding Botulinum Neurotoxin Type A Complexes in Clostridium Botulinum Type A, Ab, and A(B) Strains","volume":"70","author":"Franciosa","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Smith, T.J., Hill, K.K., Foley, B.T., Detter, J.C., Munk, A.C., Bruce, D.C., Doggett, N.A., Smith, L.A., Marks, J.D., and Xie, G. (2007). Analysis of the Neurotoxin Complex Genes in Clostridium Botulinum A1-A4 and B1 Strains: BoNT\/A3, \/Ba4 and \/B1 Clusters Are Located within Plasmids. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0001271"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kull, S., Schulz, K.M., Weisemann, J., Kirchner, S., Schreiber, T., Bollenbach, A., Dabrowski, P.W., Nitsche, A., Kalb, S.R., and Dorner, M.B. (2015). Isolation and Functional Characterization of the Novel Clostridium Botulinum Neurotoxin A8 Subtype. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116381"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1128\/AEM.01009-09","article-title":"Neurotoxin Gene Clusters in Clostridium Botulinum Type Ab Strains","volume":"75","author":"Raphael","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/JCM.00799-09","article-title":"Novel Clostridium Botulinum Toxin Gene Arrangement with Subtype A5 and Partial Subtype B3 Botulinum Neurotoxin Genes","volume":"47","author":"Dover","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35617","DOI":"10.1074\/jbc.M113.521179","article-title":"Crystal Structure of Clostridium Botulinum Whole Hemagglutinin Reveals a Huge Triskelion-Shaped Molecular Complex","volume":"288","author":"Amatsu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.toxicon.2010.12.019","article-title":"Studies on the Dissociation of Botulinum Neurotoxin Type A Complexes","volume":"57","author":"Eisele","year":"2011","journal-title":"Toxicon"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1873-3468.13446","article-title":"Crystal Structure of the Catalytic Domain of the Weissella Oryzae Botulinum-like Toxin","volume":"593","author":"Masuyer","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/1873-3468.14542","article-title":"Crystal Structure of the OrfX1-OrfX3 Complex from the PMP1 Neurotoxin Gene Cluster","volume":"597","author":"Stenmark","year":"2023","journal-title":"FEBS Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1002\/1873-3468.12889","article-title":"Crystal Structures of OrfX2 and P47 from a Botulinum Neurotoxin OrfX-Type Gene Cluster","volume":"591","author":"Gustafsson","year":"2017","journal-title":"FEBS Lett."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/1873-3468.14576","article-title":"Crystal Structures of OrfX1, OrfX2 and the OrfX1-OrfX3 Complex from the orfX Gene Cluster of Botulinum Neurotoxin E1","volume":"597","author":"Gao","year":"2023","journal-title":"FEBS Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41594-024-01479-0","article-title":"Botulinum Neurotoxins Exploit Host Digestive Proteases to Boost Their Oral Toxicity via Activating OrfXs\/P47","volume":"32","author":"Gao","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Nowakowska, M.B., Douillard, F.P., and Lindstr\u00f6m, M. (2019). Looking for the X Factor in Bacterial Pathogenesis: Association of orfX-P47 Gene Clusters with Toxin Genes in Clostridial and Non-Clostridial Bacterial Species. Toxins, 12.","DOI":"10.3390\/toxins12010019"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum Toxin as a Biological Weapon: Medical and Public Health Management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/mr.56.1.80-99.1992","article-title":"Properties and Use of Botulinum Toxin and Other Microbial Neurotoxins in Medicine","volume":"56","author":"Schantz","year":"1992","journal-title":"Microbiol. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Foster, K.A. (2014). Absorption and Transport of Botulinum Neurotoxins. Molecular Aspects of Botulinum Neurotoxin, Springer.","DOI":"10.1007\/978-1-4614-9454-6"},{"key":"ref_39","first-page":"307","article-title":"The Absorption of Clostridium Botulinum Type A Toxin from the Alimentary Canal","volume":"39","author":"May","year":"1958","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/iai.17.3.491-496.1977","article-title":"Intestinal Absorption of Botulinum Toxins of Different Molecular Sizes in Rats","volume":"17","author":"Sugii","year":"1977","journal-title":"Infect. Immun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e12738","DOI":"10.1111\/cmi.12738","article-title":"Botulinum Neurotoxin Type B Uses a Distinct Entry Pathway Mediated by CDC42 into Intestinal Cells versus Neuronal Cells","volume":"19","author":"Connan","year":"2017","journal-title":"Cell. Microbiol."},{"key":"ref_42","first-page":"375","article-title":"Receptor-Mediated Transcytosis of Botulinum Neurotoxin A through Intestinal Cell Monolayers","volume":"10","author":"Couesnon","year":"2007","journal-title":"Cell. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/cmi.12424","article-title":"Translocation of Botulinum Neurotoxin Serotype A and Associated Proteins across the Intestinal Epithelia","volume":"17","author":"Lam","year":"2015","journal-title":"Cell. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/cmi.12502","article-title":"Translocation and Dissemination to Target Neurons of Botulinum Neurotoxin Type B in the Mouse Intestinal Wall","volume":"18","author":"Connan","year":"2015","journal-title":"Cell. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Couesnon, A., Molg\u00f3, J., Connan, C., and Popoff, M.R. (2012). Preferential Entry of Botulinum Neurotoxin A Hc Domain through Intestinal Crypt Cells and Targeting to Cholinergic Neurons of the Mouse Intestine. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002583"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/toxins6020624","article-title":"Botulinum Neurotoxin A Complex Recognizes Host Carbohydrates through Its Hemagglutinin Component","volume":"6","author":"Yao","year":"2014","journal-title":"Toxins"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(00)01147-9","article-title":"Identification and Characterization of Functional Subunits of Clostridium Botulinum Type A Progenitor Toxin Involved in Binding to Intestinal Microvilli and Erythrocytes","volume":"467","author":"Fujinaga","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_48","first-page":"115","article-title":"Host-Cell Specificity and Transcytosis of Nontoxic Nonhemagglutinin Protein of Botulinum Neurotoxin Serotype D","volume":"357","author":"Miyashita","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/1574-6968.12205","article-title":"Transport of the Botulinum Neurotoxin-Associating Protein, Nontoxic Nonhemagglutinin, across the Rat Small Intestinal Epithelial Cell Monolayer","volume":"346","author":"Miyashita","year":"2013","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1099\/00221287-143-12-3841","article-title":"The Haemagglutinin of Clostridium Botulinum Type C Progenitor Toxin Plays an Essential Role in Binding of Toxin to the Epithelial Cells of Guinea Pig Small Intestine, Leading to the Efficient Absorption of the Toxin","volume":"143","author":"Fujinaga","year":"1997","journal-title":"Microbiology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1038\/s41467-025-65384-w","article-title":"Gut Mucin Fucosylation Dictates the Entry of Botulinum Toxin Complexes","volume":"16","author":"Amatsu","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Morimoto, C., Amatsu, S., Matsumura, T., Zuka, M., and Fujinaga, Y. (2025). Botulinum Toxin Complex Serotype B-Okra Exerts Systemic Toxicity via the Oral Route by Disrupting the Intestinal Epithelial Barrier. Toxins, 17.","DOI":"10.20944\/preprints202507.0898.v1"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, Y., Pan, J., Liu, H., and Liu, C. (2025). Intestinal Mucin Glycosylation: Structural Regulation, Homeostasis Maintenance and Disease Association. Biomolecules, 15.","DOI":"10.3390\/biom15111552"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Hu, M., Zhang, X., Li, J., Chen, L., He, X., and Sui, T. (2022). Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.940196"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/gbe\/evw101","article-title":"Diversity of Group I and II Clostridium Botulinum Strains from France Including Recently Identified Subtypes","volume":"8","author":"Mazuet","year":"2016","journal-title":"Genome Biol. Evol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rasetti-Escargueil, C., Lemichez, E., and Popoff, M.R. (2020). Human Botulism in France, 1875\u20132016. Toxins, 12.","DOI":"10.3390\/toxins12050338"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Rasetti-Escargueil, C., Lemichez, E., and Popoff, M.R. (2019). Public Health Risk Associated with Botulism as Foodborne Zoonoses. Toxins, 12.","DOI":"10.3390\/toxins12010017"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Sugawara, Y., Yutani, M., Amatsu, S., Matsumura, T., and Fujinaga, Y. (2014). Functional Dissection of the Clostridium Botulinum Type B Hemagglutinin Complex: Identification of the Carbohydrate and E-Cadherin Binding Sites. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111170"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1126\/science.1253823","article-title":"Molecular Basis for Disruption of E-Cadherin Adhesion by Botulinum Neurotoxin A Complex","volume":"344","author":"Lee","year":"2014","journal-title":"Science"},{"key":"ref_60","first-page":"355","article-title":"The HA Proteins of Botulinum Toxin Disrupt Intestinal Epithelial Intercellular Junctions to Increase Toxin Absorption","volume":"10","author":"Matsumura","year":"2007","journal-title":"Cell. Microbiol."},{"key":"ref_61","first-page":"45","article-title":"Uptake of Botulinum Neurotoxin in the Intestine","volume":"364","author":"Fujinaga","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1099\/mic.0.021246-0","article-title":"Disruption of the Epithelial Barrier by Botulinum Haemagglutinin (HA) Proteins\u2014Differences in Cell Tropism and the Mechanism of Action between HA Proteins of Types A or B, and HA Proteins of Type C","volume":"155","author":"Jin","year":"2009","journal-title":"Microbiology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200910119","article-title":"Botulinum Hemagglutinin Disrupts the Intercellular Epithelial Barrier by Directly Binding E-Cadherin","volume":"189","author":"Sugawara","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bbrc.2014.03.008","article-title":"High-Resolution Crystal Structure of HA33 of Botulinum Neurotoxin Type B Progenitor Toxin Complex","volume":"446","author":"Lee","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1038\/ncomms7255","article-title":"Botulinum Toxin A Complex Exploits Intestinal M Cells to Enter the Host and Exert Neurotoxicity","volume":"6","author":"Matsumura","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinids\/1.4.663","article-title":"Absorption of Botulinal Toxin from the Gastrointestinal Tract","volume":"1","author":"Bonventre","year":"1979","journal-title":"Rev. Infect. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0163-7258(82)90061-4","article-title":"Clostridium Botulinum Toxins","volume":"19","author":"Sakaguchi","year":"1982","journal-title":"Pharmacol. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of Gastrointestinal pH Profiles in Normal Ambulant Human Subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1038\/s41564-024-01856-x","article-title":"Gut Physiology and Environment Explain Variations in Human Gut Microbiome Composition and Metabolism","volume":"9","author":"Laursen","year":"2024","journal-title":"Nat. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3168\/jdsc.2021-0158","article-title":"Daily Fecal pH Pattern and Variation in Lactating Dairy Cows","volume":"3","author":"Palladino","year":"2022","journal-title":"JDS Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1051\/rnd:19610305","article-title":"Le pH Dans Le Tube Digestif Des Oiseaux","volume":"1","author":"Herpol","year":"1961","journal-title":"Ann. Biol. Anim. Biochim. Biophys."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1211\/jpp.60.1.0008","article-title":"Measurements of Rat and Mouse Gastrointestinal pH, Fluid and Lymphoid Tissue, and Implications for in-Vivo Experiments","volume":"60","author":"McConnell","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejps.2010.09.019","article-title":"Assessment of Gastrointestinal pH, Fluid and Lymphoid Tissue in the Guinea Pig, Rabbit and Pig, and Implications for Their Use in Drug Development","volume":"42","author":"Merchant","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tim.2004.08.002","article-title":"Presynaptic Receptor Arrays for Clostridial Neurotoxins","volume":"12","author":"Montecucco","year":"2004","journal-title":"Trends Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0968-0004(86)90282-3","article-title":"How Do Tetanus and Botulinum Toxins Bind to Neuronal Membranes?","volume":"11","author":"Montecucco","year":"1986","journal-title":"Trends Biochem. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"32274","DOI":"10.1074\/jbc.M103285200","article-title":"The Crystal Structure of Tetanus Toxin Hc Fragment Complexed with a Synthetic GT1b Analogue Suggests Cross-Linking between Ganglioside Receptors and the Toxin","volume":"276","author":"Fotinou","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_77","first-page":"1","article-title":"Two Feet on the Membrane: Uptake of Clostridial Neurotoxins","volume":"Volume 406","author":"Rummel","year":"2017","journal-title":"Uptake and Trafficking of Protein Toxins"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"26569","DOI":"10.1074\/jbc.M109.027391","article-title":"Gangliosides as High Affinity Receptors for Tetanus Neurotoxin","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Stern, D., Weisemann, J., Le Blanc, A., von Berg, L., Mahrhold, S., Piesker, J., Laue, M., Luppa, P.B., Dorner, M.B., and Dorner, B.G. (2018). A Lipid-Binding Loop of Botulinum Neurotoxin Serotypes B, DC and G Is an Essential Feature to Confer Their Exquisite Potency. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007048"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41467-017-01534-z","article-title":"Structural Basis for the Unique Ganglioside and Cell Membrane Recognition Mechanism of Botulinum Neurotoxin DC","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcdb.2019.02.003","article-title":"Synaptic Vesicle Protein 2: A Multi-Faceted Regulator of Secretion","volume":"95","author":"Ciruelas","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1021\/acschemneuro.9b00351","article-title":"The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance","volume":"10","author":"Stout","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.biochem.77.062005.101135","article-title":"How Does Synaptotagmin Trigger Neurotransmitter Release?","volume":"77","author":"Chapman","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 Is the Protein Receptor for Botulinum Neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12732","article-title":"Structural Basis for Recognition of Synaptic Vesicle Protein 2C by Botulinum Neurotoxin A","volume":"505","author":"Benoit","year":"2014","journal-title":"Nature"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.febslet.2014.02.034","article-title":"Identification of the Synaptic Vesicle Glycoprotein 2 Receptor Binding Site in Botulinum Neurotoxin A","volume":"588","author":"Strotmeier","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1038\/s41467-023-37860-8","article-title":"Structural Basis for Botulinum Neurotoxin E Recognition of Synaptic Vesicle Protein 2","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1042\/BJ20130391","article-title":"Identification of the SV2 Protein Receptor-Binding Site of Botulinum Neurotoxin Type E","volume":"453","author":"Mahrhold","year":"2013","journal-title":"Biochem. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/acs.biochem.6b01246","article-title":"Insights into the Mechanisms by Which Clostridial Neurotoxins Discriminate between Gangliosides","volume":"56","author":"Burns","year":"2017","journal-title":"Biochemistry"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/jacs.6b09534","article-title":"Glycans Confer Specificity to the Recognition of Ganglioside Receptors by Botulinum Neurotoxin A","volume":"139","author":"Hamark","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"43588","DOI":"10.1038\/srep43588","article-title":"Crystal Structure of the BoNT\/A2 Receptor-Binding Domain in Complex with the Luminal Domain of Its Neuronal Receptor SV2C","volume":"7","author":"Benoit","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1042\/BCJ20160439","article-title":"Only the Complex N559-Glycan in the Synaptic Vesicle Glycoprotein 2C Mediates High Affinity Binding to Botulinum Neurotoxin Serotype A1","volume":"473","author":"Mahrhold","year":"2016","journal-title":"Biochem. J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nsmb.3245","article-title":"N-Linked Glycosylation of SV2 Is Required for Binding and Uptake of Botulinum Neurotoxin A","volume":"23","author":"Yao","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.e08-07-0765","article-title":"Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons","volume":"19","author":"Dong","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nature05411","article-title":"Structural Basis of Cell Surface Receptor Recognition by Botulinum Neurotoxin B","volume":"444","author":"Chai","year":"2006","journal-title":"Nature"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/nature05387","article-title":"Botulinum Neurotoxin B Recognizes Its Protein Receptor with High Affinity and Specificity","volume":"444","author":"Jin","year":"2006","journal-title":"Nature"},{"key":"ref_97","first-page":"3233","article-title":"Botulinum Neurotoxin D-C Uses Synaptotagmin I and II as Receptors, and Human Synaptotagmin II Is Not an Effective Receptor for Type B, D-C and G Toxins","volume":"125","author":"Peng","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","article-title":"Human Synaptotagmin-II Is Not a High Affinity Receptor for Botulinum Neurotoxin B and G: Increased Therapeutic Dosage and Immunogenicity","volume":"586","author":"Strotmeier","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_99","first-page":"491","article-title":"Synaptotagmin Binding to Botulinum Neurotoxins","volume":"59","author":"Blasco","year":"2019","journal-title":"Biochemistry"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1074\/jbc.R100052200","article-title":"Synaptotagmins: Why so Many?","volume":"277","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1523\/JNEUROSCI.3519-06.2006","article-title":"Synaptotagmin-2 Is Essential for Survival and Contributes to Ca2+ Triggering of Neurotransmitter Release in Central and Neuromuscular Synapses","volume":"26","author":"Pang","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajhg.2014.08.007","article-title":"Synaptotagmin 2 Mutations Cause an Autosomal-Dominant Form of Lambert-Eaton Myasthenic Syndrome and Nonprogressive Motor Neuropathy","volume":"95","author":"Herrmann","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.toxicon.2020.02.006","article-title":"Neuronal Selectivity of Botulinum Neurotoxins","volume":"178","author":"Poulain","year":"2020","journal-title":"Toxicon"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Thaker, H., Zhang, J., Miyashita, S.-I., Cristofaro, V., Park, S., Hashemi Gheinani, A., Sullivan, M.P., Adam, R.M., and Dong, M. (2021). Knockin Mouse Models Demonstrate Differential Contributions of Synaptotagmin-1 and -2 as Receptors for Botulinum Neurotoxins. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009994"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10286-003-0118-2","article-title":"Botulism Type B Presenting as Pure Autonomic Dysfunction","volume":"13","author":"Merz","year":"2003","journal-title":"Clin. Auton. Res."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Potulska-Chromik, A., Zakrzewska-Pniewska, B., Szmidt-Sa\u0142kowska, E., Lewandowski, J., Si\u0144ski, M., Przyja\u0142kowski, W., and Kostera-Pruszczyk, A. (2013). Long Lasting Dysautonomia Due to Botulinum Toxin B Poisoning: Clinical-Laboratory Follow up and Difficulties in Initial Diagnosis. BMC Res. Notes, 6.","DOI":"10.1186\/1756-0500-6-438"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1083\/jcb.200305098","article-title":"Synaptotagmins I and II Mediate Entry of Botulinum Neurotoxin B into Cells","volume":"162","author":"Dong","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"18098","DOI":"10.1073\/pnas.1908051116","article-title":"Gangliosides Interact with Synaptotagmin to Form the High-Affinity Receptor Complex for Botulinum Neurotoxin B","volume":"116","author":"Flores","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00018-022-04527-4","article-title":"Molecular Landscape of BoNT\/B Bound to a Membrane-Inserted Synaptotagmin\/Ganglioside Complex","volume":"79","author":"Azzaz","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"40806","DOI":"10.1074\/jbc.M112.404244","article-title":"Botulinum Neurotoxin Serotype C Associates with Dual Ganglioside Receptors to Facilitate Cell Entry","volume":"287","author":"Karalewitz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/BJ20101042","article-title":"Botulinum Neurotoxin Serotype D Attacks Neurons via Two Carbohydrate-Binding Sites in a Ganglioside-Dependent Manner","volume":"431","author":"Strotmeier","year":"2010","journal-title":"Biochem. J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2958.2011.07682.x","article-title":"The Biological Activity of Botulinum Neurotoxin Type C Is Dependent upon Novel Types of Ganglioside Binding Sites","volume":"81","author":"Strotmeier","year":"2011","journal-title":"Mol. Microbiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"8889","DOI":"10.1074\/jbc.275.12.8889","article-title":"The Structures of the H(C) Fragment of Tetanus Toxin with Carbohydrate Subunit Complexes Provide Insight into Ganglioside Binding","volume":"275","author":"Emsley","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1111\/jnc.16186","article-title":"SV2A Controls the Surface Nanoclustering and Endocytic Recruitment of Syt1 during Synaptic Vesicle Recycling","volume":"168","author":"Small","year":"2024","journal-title":"J. Neurochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e16308","DOI":"10.1111\/jnc.16308","article-title":"Control of Synaptotagmin-1 Trafficking by SV2A-Mechanism and Consequences for Presynaptic Function and Dysfunction","volume":"169","author":"Hogg","year":"2025","journal-title":"J. Neurochem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e112095","DOI":"10.15252\/embj.2022112095","article-title":"Presynaptic Targeting of Botulinum Neurotoxin Type A Requires a Tripartite PSG-Syt1-SV2 Plasma Membrane Nanocluster for Synaptic Vesicle Entry","volume":"42","author":"Joensuu","year":"2023","journal-title":"EMBO J."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Peng, L., Tepp, W.H., Johnson, E.A., and Dong, M. (2011). Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002008"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"19654","DOI":"10.1038\/srep19654","article-title":"Botulinum Neurotoxin Type-A Enters a Non-Recycling Pool of Synaptic Vesicles","volume":"6","author":"Harper","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41467-025-56304-z","article-title":"Cryo-EM Structure of the Botulinum Neurotoxin A\/SV2B Complex and Its Implications for Translocation","volume":"16","author":"Khanppnavar","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.15252\/embr.201744198","article-title":"The Structure of the Tetanus Toxin Reveals pH-Mediated Domain Dynamics","volume":"18","author":"Masuyer","year":"2017","journal-title":"EMBO Rep."},{"key":"ref_121","unstructured":"Alouf, J., Ladant, D., and Popoff, M.R. (2015). 11\u2014Clostridial Neurotoxins: From the Cellular and Molecular Mode of Action to Their Therapeutic Use. The Comprehensive Sourcebook of Bacterial Protein Toxins, Academic Press. [4th ed.]."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00204-022-03271-9","article-title":"Toxicology and Pharmacology of Botulinum and Tetanus Neurotoxins: An Update","volume":"96","author":"Pirazzini","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"E5158","DOI":"10.1073\/pnas.1621076114","article-title":"Deubiquitinating Enzyme VCIP135 Dictates the Duration of Botulinum Neurotoxin Type A Intoxication","volume":"114","author":"Tsai","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"16554","DOI":"10.1073\/pnas.1008302107","article-title":"Targeting Botulinum Neurotoxin Persistence by the Ubiquitin-Proteasome System","volume":"107","author":"Tsai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.1074\/jbc.M110.181784","article-title":"A Dileucine in the Protease of Botulinum Toxin A Underlies Its Long-Lived Neuroparalysis: Transfer of Longevity to a Novel Potential Therapeutic","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Gardner, A.P., Barbieri, J.T., and Pellett, S. (2022). How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane. Toxins, 14.","DOI":"10.3390\/toxins14120814"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Gardner, A., Tepp, W.H., Bradshaw, M., Barbieri, J.T., and Pellett, S. (2021). Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011115"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s42003-025-08633-4","article-title":"Botulinum Neurotoxin Light Chain\/A1 Uses Fast Synaptic Vesicle Cycling to Cleave Plasma Membrane Bound SNAP-25","volume":"8","author":"Gardner","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Sch\u00fcmann, F., Schmitt, O., Wree, A., and Hawlitschka, A. (2023). Distribution of Cleaved SNAP-25 in the Rat Brain, Following Unilateral Injection of Botulinum Neurotoxin-A into the Striatum. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021685"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Koc, D., Ezgin, S., Kavakli, E., Kota, K.P., Sen, E., Mahone, C., Palko, M.E., Cazares, L.H., Can, T., and Tessarollo, L. (2025). Phosphorylation of SNAP-25 at Ser187 Is Enhanced Following Its Cleavage by Botulinum Neurotoxin Serotype A, Promoting the Dominant-Negative Effect of the Resulting Fragment. PLoS Pathog., 21.","DOI":"10.1371\/journal.ppat.1013604"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/sj.embor.7400278","article-title":"A Molecular Basis Underlying Differences in the Toxicity of Botulinum Serotypes A and E","volume":"5","author":"Bajohrs","year":"2004","journal-title":"EMBO Rep."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e1065","DOI":"10.7717\/peerj.1065","article-title":"The Destructive Effect of Botulinum Neurotoxins on the SNARE Protein: SNAP-25 and Synaptic Membrane Fusion","volume":"3","author":"Lu","year":"2015","journal-title":"PeerJ"},{"key":"ref_133","unstructured":"Alouf, J., Ladant, D., and Popoff, M.R. (2015). 12\u2014Uptake and Transport of Clostridial Neurotoxins. The Comprehensive Sourcebook of Bacterial Protein Toxins, Academic Press. [4th ed.]."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"NS20220098","DOI":"10.1042\/NS20220098","article-title":"In Vivo Imaging of Axonal Transport in Peripheral Nerves of Rodent Forelimbs","volume":"7","author":"Lang","year":"2023","journal-title":"Neuronal Signal."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.ajpath.2024.05.009","article-title":"Local Tetanus Begins with a Neuromuscular Junction Paralysis around the Site of Tetanus Neurotoxin Release Due to Cleavage of the Vesicle-Associated Membrane Protein","volume":"194","author":"Fabris","year":"2024","journal-title":"Am. J. Pathol."},{"key":"ref_136","first-page":"e166978","article-title":"Facial Neuromuscular Junctions and Brainstem Nuclei Are the Target of Tetanus Neurotoxin in Cephalic Tetanus","volume":"8","author":"Fabris","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-2836(02)01403-1","article-title":"Two Carbohydrate Binding Sites in the H(CC)-Domain of Tetanus Neurotoxin Are Required for Toxicity","volume":"326","author":"Rummel","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1074\/jbc.R200027200","article-title":"The Basement Membrane\/Basal Lamina of Skeletal Muscle","volume":"278","author":"Sanes","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13578-021-00579-4","article-title":"Extracellular Matrix: An Important Regulator of Cell Functions and Skeletal Muscle Development","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Biosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jemt.20567","article-title":"Nidogens-Extracellular Matrix Linker Molecules","volume":"71","author":"Ho","year":"2008","journal-title":"Microsc. Res. Tech."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1023\/B:NEUR.0000020630.74955.19","article-title":"Basal Lamina and the Organization of Neuromuscular Synapses","volume":"32","author":"Patton","year":"2003","journal-title":"J. Neurocytol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.gendis.2021.03.004","article-title":"Nidogen: A Matrix Protein with Potential Roles in Musculoskeletal Tissue Regeneration","volume":"9","author":"Zhou","year":"2022","journal-title":"Genes Dis."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1038\/s44318-024-00164-8","article-title":"The Tyrosine Phosphatases LAR and PTPR\u03b4 Act as Receptors of the Nidogen-Tetanus Toxin Complex","volume":"43","author":"Surana","year":"2024","journal-title":"EMBO J."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Cornejo, F., Cort\u00e9s, B.I., Findlay, G.M., and Cancino, G.I. (2021). LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.659951"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxicon.2017.10.008","article-title":"The Travel Diaries of Tetanus and Botulinum Neurotoxins","volume":"147","author":"Surana","year":"2018","journal-title":"Toxicon"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.1258138","article-title":"Tetanus Toxin Entry. Nidogens Are Therapeutic Targets for the Prevention of Tetanus","volume":"346","author":"Bercsenyi","year":"2014","journal-title":"Science"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.200508170","article-title":"Tetanus Toxin Is Internalized by a Sequential Clathrin-Dependent Mechanism Initiated within Lipid Microdomains and Independent of Epsin1","volume":"174","author":"Deinhardt","year":"2006","journal-title":"J. Cell Biol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/neu.20291","article-title":"LAR Protein Tyrosine Phosphatase Receptor Associates with TrkB and Modulates Neurotrophic Signaling Pathways","volume":"66","author":"Yang","year":"2006","journal-title":"J. Neurobiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0006-291X(02)00928-2","article-title":"Some Protein Tyrosine Phosphatases Target in Part to Lipid Rafts and Interact with Caveolin-1","volume":"296","author":"Caselli","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e201905071","DOI":"10.1083\/jcb.201905071","article-title":"Caveolae and Lipid Sorting: Shaping the Cellular Response to Stress","volume":"219","author":"Parton","year":"2020","journal-title":"J. Cell Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1034\/j.1600-0854.2002.30501.x","article-title":"Endocytosis via Caveolae","volume":"3","author":"Pelkmans","year":"2002","journal-title":"Traffic"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1083\/jcb.200106142","article-title":"Analysis of Retrograde Transport in Motor Neurons Reveals Common Endocytic Carriers for Tetanus Toxin and Neurotrophin Receptor p75NTR","volume":"156","author":"Lalli","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tins.2013.06.002","article-title":"Protein Tyrosine Phosphatases PTP\u03b4, PTP\u03c3, and LAR: Presynaptic Hubs for Synapse Organization","volume":"36","author":"Takahashi","year":"2013","journal-title":"Trends Neurosci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuron.2006.08.018","article-title":"Rab5 and Rab7 Control Endocytic Sorting along the Axonal Retrograde Transport Pathway","volume":"52","author":"Deinhardt","year":"2006","journal-title":"Neuron"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jnc.15330","article-title":"Tetanus and Tetanus Neurotoxin: From Peripheral Uptake to Central Nervous Tissue Targets","volume":"158","author":"Megighian","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"44474","DOI":"10.1038\/srep44474","article-title":"Neuronal Entry and High Neurotoxicity of Botulinum Neurotoxin A Require Its N-Terminal Binding Sub-Domain","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the Two Subdomains of the C-Terminal Part of the Botulinum Neurotoxin A Is Essential for the Generation of Protective Antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The Synaptic Vesicle Protein 2C Mediates the Uptake of Botulinum Neurotoxin A into Phrenic Nerves","volume":"580","author":"Mahrhold","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s41467-025-59545-0","article-title":"Structures of Native SV2A Reveal the Binding Mode for Tetanus Neurotoxin and Anti-Epileptic Racetams","volume":"16","author":"Schenck","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Yeh, F.L., Dong, M., Yao, J., Tepp, W.H., Lin, G., Johnson, E.A., and Chapman, E.R. (2010). SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001207"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2017.07.029","article-title":"Synaptic Vesicle 2C and Its Synaptic-Related Function","volume":"472","author":"Hu","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Pint\u00e9r, P., and Alp\u00e1r, A. (2022). The Role of Extracellular Matrix in Human Neurodegenerative Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911085"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s10571-021-01073-8","article-title":"Changes in the Brain Extracellular Matrix Composition in Schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target","volume":"42","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.celrep.2014.08.017","article-title":"Thioredoxin and Its Reductase Are Present on Synaptic Vesicles, and Their Inhibition Prevents the Paralysis Induced by Botulinum Neurotoxins","volume":"8","author":"Pirazzini","year":"2014","journal-title":"Cell Rep."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxicon.2017.10.028","article-title":"Hsp90 and Thioredoxin-Thioredoxin Reductase Enable the Catalytic Activity of Clostridial Neurotoxins inside Nerve Terminals","volume":"147","author":"Pirazzini","year":"2018","journal-title":"Toxicon"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Restani, L., Giribaldi, F., Manich, M., Bercsenyi, K., Menendez, G., Rossetto, O., Caleo, M., and Schiavo, G. (2012). Botulinum Neurotoxins A and E Undergo Retrograde Axonal Transport in Primary Motor Neurons. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003087"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Jacky, B.P.S., Garay, P.E., Dupuy, J., Nelson, J.B., Cai, B., Molina, Y., Wang, J., Steward, L.E., Broide, R.S., and Francis, J. (2013). Identification of Fibroblast Growth Factor Receptor 3 (FGFR3) as a Protein Receptor for Botulinum Neurotoxin Serotype A (BoNT\/A). PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003369"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1038\/s41598-021-87331-7","article-title":"Characterization of Clostridium Botulinum Neurotoxin Serotype A (BoNT\/A) and Fibroblast Growth Factor Receptor Interactions Using Novel Receptor Dimerization Assay","volume":"11","author":"James","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1073858414524633","article-title":"More than at the Neuromuscular Synapse: Actions of Botulinum Neurotoxin A in the Central Nervous System","volume":"21","author":"Mazzocchio","year":"2015","journal-title":"Neuroscientist"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1523\/JNEUROSCI.3757-14.2015","article-title":"Control of Autophagosome Axonal Retrograde Flux by Presynaptic Activity Unveiled Using Botulinum Neurotoxin Type a","volume":"35","author":"Wang","year":"2015","journal-title":"J. Neurosci."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-Distance Retrograde Effects of Botulinum Neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1600-0854.2012.01369.x","article-title":"Botulinum Neurotoxin A Impairs Neurotransmission Following Retrograde Transynaptic Transport","volume":"13","author":"Restani","year":"2012","journal-title":"Traffic"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuint.2012.05.001","article-title":"Botulinum Toxin\u2019s Axonal Transport from Periphery to the Spinal Cord","volume":"61","author":"Matak","year":"2012","journal-title":"Neurochem. Int."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Koizumi, H., Goto, S., Okita, S., Morigaki, R., Akaike, N., Torii, Y., Harakawa, T., Ginnaga, A., and Kaji, R. (2014). Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2. Front. Neurol., 5.","DOI":"10.3389\/fneur.2014.00098"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","article-title":"Transsynaptic Inhibition of Spinal Transmission by A2 Botulinum Toxin","volume":"591","author":"Akaike","year":"2013","journal-title":"J. Physiol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1523\/JNEUROSCI.0294-18.2018","article-title":"Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons","volume":"38","author":"Caleo","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2016.06.104","article-title":"Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons","volume":"16","author":"Vevea","year":"2016","journal-title":"Cell Rep."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Markopoulou, S., Vardouli, L., Dimitriadis, F., Psalla, D., Lambropoulos, A., and Apostolidis, A. (2022). Effect of Bladder Injection of OnabotulinumtoxinA on the Central Expression of Genes Associated with the Control of the Lower Urinary Tract: A Study in Normal Rats. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214419"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/bju.13163","article-title":"Retrograde Transport of Radiolabelled Botulinum Neurotoxin Type A to the CNS after Intradetrusor Injection in Rats","volume":"117","author":"Papagiannopoulou","year":"2016","journal-title":"BJU Int."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bph.14846","article-title":"Evidence for Central Antispastic Effect of Botulinum Toxin Type A","volume":"177","author":"Matak","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e00173","DOI":"10.1002\/phy2.173","article-title":"Spinal Plasticity in Stroke Patients after Botulinum Neurotoxin A Injection in Ankle Plantar Flexors","volume":"1","author":"Aymard","year":"2013","journal-title":"Physiol. Rep."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1113\/jphysiol.2012.239178","article-title":"Beyond Muscular Effects: Depression of Spinal Recurrent Inhibition after Botulinum Neurotoxin A","volume":"591","author":"Aymard","year":"2013","journal-title":"J. Physiol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"176242","DOI":"10.1016\/j.ejphar.2023.176242","article-title":"Beyond Neuromuscular Activity: Botulinum Toxin Type A Exerts Direct Central Action on Spinal Control of Movement","volume":"962","author":"Cifrek","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Hok, P., Veverka, T., Hlu\u0161t\u00edk, P., Nevrl\u00fd, M., and Ka\u0148ovsk\u00fd, P. (2021). The Central Effects of Botulinum Toxin in Dystonia and Spasticity. Toxins, 13.","DOI":"10.3390\/toxins13020155"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2340\/16501977-2257","article-title":"Centrally Mediated Late Motor Recovery after Botulinum Toxin Injection: Case Reports and a Review of Current Evidence","volume":"49","author":"Mas","year":"2017","journal-title":"J. Rehabil. Med."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Fabillar, J., Yamamoto, Y., Koike, K., Ikutame, D., and Matsuka, Y. (2025). Updates on the Proposed Botulinum Toxin A Mechanisms of Action in Orofacial Pain: A Review of Animal Studies. Toxins, 17.","DOI":"10.3390\/toxins17120567"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3390\/toxins7072454","article-title":"Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation","volume":"7","author":"Intiso","year":"2015","journal-title":"Toxins"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Matak, I., B\u00f6lcskei, K., Bach-Rojecky, L., and Helyes, Z. (2019). Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins, 11.","DOI":"10.3390\/toxins11080459"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Nemani\u0107, D., \u0160o\u0161tari\u0107, P., Megli\u0107, P., Matak, I., and Bach-Rojecky, L. (2025). Botulinum Toxin Type A Exerts Direct Trans-Synaptic Action at Bilateral Spinal Nociceptive Circuits. Toxins, 17.","DOI":"10.3390\/toxins17030140"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Park, J., and Chung, M.E. (2018). Botulinum Toxin for Central Neuropathic Pain. Toxins, 10.","DOI":"10.3390\/toxins10060224"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"105952","DOI":"10.1016\/j.nbd.2022.105952","article-title":"Schwann Cell Functions in Peripheral Nerve Development and Repair","volume":"176","author":"Fledrich","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s42004-025-01569-0","article-title":"Botulinum Neurotoxin A Mutants with Enhanced Ganglioside Binding Show Improved Potency and Altered Ganglioside Selectivity","volume":"8","author":"Masuyer","year":"2025","journal-title":"Commun. Chem."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"107264","DOI":"10.1016\/j.toxicon.2023.107264","article-title":"A Look at the Future\u2014New BoNTs and Delivery Systems in Development: What It Could Mean in the Clinic","volume":"234","author":"Kaji","year":"2023","journal-title":"Toxicon"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/164_2020_351","article-title":"Novel Native and Engineered Botulinum Neurotoxins","volume":"263","author":"Steward","year":"2021","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Zhantleuova, A., Leese, C., Andreou, A.P., Karimova, A., Carpenter, G., and Davletov, B. (2024). Recent Developments in Engineering Non-Paralytic Botulinum Molecules for Therapeutic Applications. Toxins, 16.","DOI":"10.3390\/toxins16040175"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Webb, R.P. (2018). Engineering of Botulinum Neurotoxins for Biomedical Applications. Toxins, 10.","DOI":"10.3390\/toxins10060231"},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Rasetti-Escargueil, C., and Popoff, M.R. (2020). Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development. Toxins, 13.","DOI":"10.3390\/toxins13010001"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/17512433.2025.2594489","article-title":"Botulinum Toxin in Focus: Evolution, Pharmacology, and Its Expanding Clinical Impact","volume":"18","author":"Khan","year":"2025","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-017-00064-y","article-title":"Engineered Botulinum Neurotoxin B with Improved Efficacy for Targeting Human Receptors","volume":"8","author":"Tao","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/2211-5463.13612","article-title":"Lipid Rafts and Human Diseases: Why We Need to Target Gangliosides","volume":"13","author":"Fantini","year":"2023","journal-title":"FEBS Open Bio"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12035-025-05381-8","article-title":"Brain-Derived Neurotrophic Factor Trafficking via the Regulated Secretory Pathway: Mechanisms and Disease Implications","volume":"63","author":"Ewell","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e168554","DOI":"10.1172\/JCI168554","article-title":"Disruption of Axonal Transport in Neurodegeneration","volume":"133","author":"Berth","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"106851","DOI":"10.1016\/j.nbd.2025.106851","article-title":"Glycosphingolipids in Neurodegeneration\u2014Molecular Mechanisms, Cellular Roles, and Therapeutic Perspectives","volume":"207","year":"2025","journal-title":"Neurobiol. Dis."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/1\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:25:58Z","timestamp":1768206358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/1\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["toxins18010035"],"URL":"https:\/\/doi.org\/10.3390\/toxins18010035","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]}}}